Zucapsaicin

Unassigned

New Medicines

Civamide; Civanex; Zuacta · Cluster headache

Information

Civamide; Civanex; Zuacta
New molecular entity
Not Known
Winston Pharmaceuticals

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Vanilloid receptor subtype-1 (TRPV-1) agonist and neuronal calcium channel blocker
Cluster headache prevalence has been variously estimated to be from 56-69 per 100,000 up to 279 per 100,000 [5].
Cluster headache
Intranasal

Evidence based evaluations